Ana C. Ward
Nessuna posizione attualmente
Profilo
Ana C.
Ward formerly worked at Yum! Brands, Inc., as Senior Intellectual Property Counsel, Asuragen, Inc., as Senior Vice President & General Counsel from 2010 to 2015, Rosetta Genomics Ltd., as Executive VP-Legal & Corporate Development, Ovid Therapeutics, Inc., as Senior Vice President & General Counsel from 2017 to 2019, Sidley & Austin, as Associate, Ambion, Inc., as General Counsel from 2003 to 2015, Mirna Therapeutics, Inc., as Senior Vice President & General Counsel from 2003 to 2015, and AptamiR Therapeutics, Inc., as Chief Operating Officer.
Ms. Ward received her undergraduate degree, graduate degree, and Masters Business Admin degree from The University of Texas at Austin, graduate degree from The Johns Hopkins University, and doctorate degree from The University of Texas School of Law.
Precedenti posizioni note di Ana C. Ward
| Società | Posizione | Fine |
|---|---|---|
| OVID THERAPEUTICS INC. | Chief Operating Officer | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | General Counsel | 01/01/2015 |
Ambion, Inc.
 Ambion, Inc. Pharmaceuticals: MajorHealth Technology Ambion, Inc. develops and supplies RNA based life science research and molecular biology products. It specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA. The company was founded in November 1988 and is headquartered in Austin, TX | General Counsel | 01/01/2015 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | General Counsel | 01/01/2015 |
AptamiR Therapeutics, Inc.
 AptamiR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services AptamiR Therapeutics, Inc. develops a revolutionary treatment for human obesity. The private company is based in Naples, FL. The company was founded by Marc Thibonnier. | Chief Operating Officer | - |
Formazione di Ana C. Ward
| The University of Texas at Austin | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| The University of Texas School of Law | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| YUM! BRANDS, INC. | Consumer Services |
| ROSETTA GENOMICS LTD. | Health Technology |
| OVID THERAPEUTICS INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
| Sidley & Austin | Commercial Services |
Ambion, Inc.
Ambion, Inc. Pharmaceuticals: MajorHealth Technology Ambion, Inc. develops and supplies RNA based life science research and molecular biology products. It specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA. The company was founded in November 1988 and is headquartered in Austin, TX | Health Technology |
AptamiR Therapeutics, Inc.
AptamiR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services AptamiR Therapeutics, Inc. develops a revolutionary treatment for human obesity. The private company is based in Naples, FL. The company was founded by Marc Thibonnier. | Commercial Services |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
- Borsa valori
- Insiders
- Ana C. Ward
